Hostname: page-component-7b7567c8c-2n9c9 Total loading time: 0 Render date: 2026-11-16T14:50:47.332Z Has data issue: false hasContentIssue false

Antidepressant selection and economic outcome: a review of methods and studies from clinical practice

Published online by Cambridge University Press:  02 January 2018

William H. Crown*
Affiliation:
The MEDSTAT Group, 125 Cambridge Park Drive, Cambridge, MA 02140, USA. Tel: + 1 617492 9309; fax: +1 617492 9365; e-mail: Bill_Crown@MEDSTAT.com
Rights & Permissions [Opens in a new window]

Abstract

Background

Economic considerations increasingly play a role in the selection of antidepressant drugs and are often based on analyses from prospective and retrospective studies. However, the non-randomisation found in retrospective studies may result in significant selection bias.

Aims

To highlight the use of statistical methods in non-randomised studies and the application of those methods to economic analyses.

Method

The literature on the observational studies of economic outcomes with alternative antidepressants is reviewed and several statistical methodologies to control for biases that can occur in non-randomised study designs are described.

Results

In comparisons of antidepressant drugs, differences in acquisition costs are consistently found to be at least offset by other components of care when broad measures of health care resource utilisation are considered.

Conclusions

Economic evaluations of antidepressants should be based on broad measures of health care expenditure and can rely on data generated in real-world settings if appropriate statistical methods are used to control for the potential biases of non-randomisation.

Information

Type
Research Article
Copyright
Copyright © Royal College of Psychiatrists, 2001 

This journal is not currently accepting new eletters.

eLetters

No eLetters have been published for this article.